Deep Brain Stimulation Market Current and Future Scenario of Global Industry till 2028

Deep brain stimulation (DBS) refers to a device used for the purpose of providing electrical incitement to some areas of the brain to control the movement. They are extensively utilized to treat diseases such as Parkinson's disease, chronic pain, central pain syndrome, epilepsy and obsessive compulsive disorder among others. Deep brain stimulation involves the surgery for implanting a device that sends a signal to brain areas responsible for body movement. DBS helps in reducing the symptoms of stiffness, slowness, and walking problems caused by various neurological diseases such as dystonia, Parkinson's disease, or essential tremor. This therapy is generally recommended to patients who do not respond to medicines for at least five years.

Download PDF Sample Copy at:
https://www.theinsightpartners.com/sample/TIPHE100000996/?utm_source=OpenPR&utm_medium=10376

MARKET SEGMENTATION

- Based on product, the global Deep brain stimulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator.
- On the basis of application, the market is segmented into parkinson's disease, tremor, depression, alzheimer's disease, dystonia and tourette syndrome.
- Based on end user, the market is categorised into hospitals, research centres.

MARKET DYNAMICS

Drivers:

- The Increasing number of patients suffering from involuntary movements associated with Parkinson's disease, dystonia, and multiple sclerosis.
- Increasing demand for minimally invasive techniques due to enhanced patient outcomes
- Growing awareness about the massive neurological disease burden has raised the demand for deep brain stimulators as an alternative therapy.

Restraints:

- High cost associated with the surgery and delay in product approvals from various government authorities.

Have a Call with Analyst:
https://www.theinsightpartners.com/speak-to-analyst/TIPHE100000996/?utm_source=OpenPR&utm_medium=10376

IMPACT OF COVID-19 ON DEEP BRAIN STIMULATION MARKET

Public health guidelines of various countries have recommended that elective medical procedures, including deep brain stimulation (DBS) surgery for Parkinson's disease (PD), should not be scheduled during the coronavirus (COVID-19) pandemic to prevent further virus spread and overload on health care systems. However, rescheduling and delaying DBS surgery for patients who suffer from advanced and medication-refractory PD may not be in the best interest of individual patients. Moreover, restricted availability of medical resources, prioritizing some elective and time-sensitive therapeutic procedures may affect the market growth to some extent. As the vaccination progress and spread of virus is set under control procedures like DBS may increase adoption rate which is expected to offer some opportunities to the market.

TOP PLAYERS

1. Abbott (St. Jude Medical)
2. Medtronic
3. Boston Scientific Corporation
4. Aleva Neurotherapeutics S.A.
5. Nexstim
6. LivaNova PLC
7. Neuropace Inc.
8. Cyberonics, Inc.
9. Nevro Corp.
10. NeuroSigma, Inc.

Buy Report at:
https://www.theinsightpartners.com/buy/TIPHE100000996/?utm_source=OpenPR&utm_medium=10376

Contact us:

If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About The Insight Partners:

The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Manufacturing and Construction, Technology, Chemicals and Materials.
We offer our clients multiple ways to customize research as per their specific needs and budget.

This release was published on openPR.